CDC director 'concerned that our public health message isn’t resonating' on masks, social distancing [Sponsored] Salesforce proactively helps providers re-engage patients and reschedule elective procedures and services delayed by the COVID-19 crisis After Operation Warp Speed picks 5 finalists, experts question why some vaccines were left out After Kaletra setback, AbbVie joins forces with biotech, academia for experimental COVID-19 hopeful Left out of Warp Speed, Novavax scores $60M defense contract for COVID-19 shot Stanford team deploys CRISPR gene editing to fight COVID-19 HHS official: 'Cat out of the bag' on telehealth but unclear what changes will stick Healthcare roundup: Intermountain offers acute-level care at home; BARDA, Evidation Health to develop COVID-19 early warning system Biopharma roundup: Former FDA chief disputes Warp Speed picks; Novavax scores defense contract for COVID shot Healthcare sector jobs increase by 312K in May thanks to dentists' offices Medicare Advantage plans face 'double whammy' of pent-up care demand and risk scores: experts FDA publishes validation data from 5 more COVID-19 antibody tests, both authorized and not Inovio accuses manufacturing partner of hampering COVID-19 vaccine scale-up in lawsuit Lonza poaches Roche exec for CEO as Moderna COVID-19 collab speeds ahead Singapore opts for countrywide wearables for COVID-19 tracing: Reuters Featured Story | Friday, June 5, 2020 Federal health officials are concerned Americans aren't using the best tools at their disposal to prevent the spread of COVID-19, Centers for Disease Control and Prevention Director Robert Redfield said Thursday. read more |
| |
|---|
|
| Friday, June 5, 2020 Many elective procedures were postponed due to COVID-19, but with the Salesforce Accelerate Elective Procedures solution, providers are able to re-engage patients and reschedule elective procedures. read more |
| |
|---|
|
Top Stories Friday, June 5, 2020 All eyes are on a handful of drug companies after news that the U.S. is prioritizing five COVID-19 vaccine programs. But since the selections went public, experts have been raising questions about the process and the drugmakers that were left off. read more Friday, June 5, 2020 Earlier this year, AbbVie tried and stumbled in a clinical trial using its HIV med Kaletra to help certain COVID-19 patients; now, it’s tapping a triumvirate of life science groups to develop a new antibody for the virus. read more Friday, June 5, 2020 Novavax wasn’t included in the U.S. government’s group of COVID-19 vaccine finalists for Operation Warp Speed, but only days after news of those picks broke, the company has picked up a contract with the U.S. Department of Defense. read more Friday, June 5, 2020 Stanford bioengineers teamed up with researchers at the Lawrence Berkeley National Laboratory to develop a CRISPR system that neutralizes SARS-CoV-2 by scrambling the virus's genetic code. They believe the technology could prove useful for combating several types of viruses, including influenza. read more Friday, June 5, 2020 An HHS official acknowledged telehealth is likely here to stay after an explosion of use due to the COVID-19 pandemic, but it remains unclear whether regulatory flexibility will become permanent. read more Friday, June 5, 2020 Follow along with the latest COVID-19 news straight from the FierceHealthcare team. read more Friday, June 5, 2020 Scott Gottlieb finds fault with Operation Warp Speed's vaccine finalists. Novavax, picked over for the project, signed a $60 million defense contract for its COVID shot. And AbbVie teamed up with biotech academia to advance studies on an antibody treatment for the virus. read more Friday, June 5, 2020 The monthly jobs report was a bright spot for the healthcare sector, which earned 312,000 more jobs in May compared to April. read more Friday, June 5, 2020 Medicare Advantage plans need to figure out how the delay of care due to the COVID-19 pandemic will impact their risk scores in the long term, experts say. read more Friday, June 5, 2020 The FDA published a new set of validation data from five additional coronavirus antibody tests, including diagnostics that have received federal authorizations and some that have since been removed from public sale. read more Friday, June 5, 2020 Vaccine maker Inovio has had a rough week after the U.S. government left the biotech off its list of candidates most likely to produce a viable COVID-19 shot within the year. Now, the company has taken its frustration out on a longtime manufacturing partner it accused of withholding technical knowledge and killing a scaled-up shot rollout. read more Friday, June 5, 2020 Lonza recently grabbed headlines with its coronavirus vaccine manufacturing partnership with Moderna. Now, the CDMO has found Pierre-Alain Ruffieux, currently head of global pharma technical operations at fellow Swiss pharma Roche, to see the deal through. read more Friday, June 5, 2020 The city-state of Singapore is planning to outfit each of its 5.7 million residents with a simple wearable device to track people who have been exposed to the novel coronavirus, according to Reuters. read more |
